NovoCure Ltd
NVCR
Market Cap$1.94B
Close$
$-5.24
130.1% downside
Current Fair Value
130.1% downsideOvervalued by 130.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.94 Billion |
|---|---|
| Enterprise Value | $2.03 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.56 |
| Beta | 0.73 |
| Outstanding Shares | 110,281,832 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.67 |
|---|---|
| PEG | 30.54 |
| Price to Sales | 3.48 |
| Price to Book Ratio | -8.69 |
| Enterprise Value to Revenue | 3.51 |
| Enterprise Value to EBIT | -17.7 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About NovoCure Ltd
CEO: Asaf Danziger